Hervé Tostivint
- Pharmacology top 1%
- Apelin-related biomedical research 22
-
- Hormonal Regulation and Hypertension 12
- Reproductive Medicine top 2%
- Hypothalamic control of reproductive hormones 6
- Physiology top 2%
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 25
-
- Cardiovascular Disease and Adiposity 9
-
- Neuropeptides and Animal Physiology 8
-
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 6
-
- Neuroendocrine Tumor Research Advances 6
Hervé Tostivint
62 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 92
- Pharmacology 877
- Endocrinology, Diabetes and Metabolism 667
- Reproductive Medicine 290
- Physiology 148
- Endocrine and Autonomic Systems 219
Countries citing papers authored by Hervé Tostivint
This map shows the geographic impact of Hervé Tostivint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Tostivint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Tostivint more than expected).
Fields of papers citing papers by Hervé Tostivint
This network shows the impact of papers produced by Hervé Tostivint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Tostivint. The network helps show where Hervé Tostivint may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hervé Tostivint, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 8 | |
| 5 | 2020 | 39 | |
| 6 | 2020 | 9 | |
| 7 | 2018 | 38 | |
| 8 | 2018 | 20 | |
| 9 | 2016 | 6 | |
| 10 | 2016 | 47 | |
| 11 | 2014 | 78 | |
| 12 | 2012 | 7 | |
| 13 | 2010 | 50 | |
| 14 | 2008 | 29 | |
| 15 | 2006 | 1 | |
| 16 | 2006 | 56 | |
| 17 | 2005 | 3 | |
| 18 | 2004 | 27 | |
| 19 | 2002 | 26 | |
| 20 | 1999 | 33 |
About Hervé Tostivint
Hervé Tostivint is a scholar working on Pharmacology, Developmental Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 63 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (25 papers), Apelin-related biomedical research (22 papers), Hormonal Regulation and Hypertension (12 papers), Cardiovascular Disease and Adiposity (9 papers), Neuropeptides and Animal Physiology (8 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers), Neuroendocrine Tumor Research Advances (6 papers) and Hypothalamic control of reproductive hormones (6 papers). The work is most often cited by research in Pharmacology (877 citations), Endocrinology, Diabetes and Metabolism (667 citations) and Reproductive Medicine (290 citations). Hervé Tostivint has collaborated with scholars based in France, Russia and Canada. Frequent co-authors include Isabelle Lihrmann, Hubert Vaudry, J. Michael Conlon, Sylvie Jégou, Hubert Vaudry, Yolaine Coulouarn, Youssef Anouar, Feng B. Quan, Sorana Ciura and Edor Kabashi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Physiological Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.